FDA warns Aspen Pharmacare, Africa’s biggest drugmaker, over sterility issues at a key plant

Taking stock of the drug industry, from the lab to the medicine chest

March 19, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Adobe STAT+ | FDA warns Aspen Pharmacare, Africa's biggest drugmaker, over sterility issues at a key plant The agency also recently issued an import alert on several medicines made at the Aspen facility in South Africa. By Ed Silverman STAT+ | Novartis finally delivers gene therapy data in older SMA patients. Will they still want it?  In the years since Zolgensma was approved for babies with spinal muscular atrophy, other treatments have hit the market. By Jason Mast Purdue Pharma submits opioid lawsuit settlement plan, including up to $7 billion cash from Sacklers The filing is a milestone in the tumultuous Purdue Pharma legal saga that has gone on for more than five years. By Associated Press STAT+ | Immunovant and Roivant report success in autoimmune drug's Phase 3 trial The companies reported Wednesday that batoclimab showed improvements in myasthenia gravis patients in a Phase 3 trial. By Adam Feuerstein STAT+ | Prime and Beam, born of same lab, pursuing rival gene-editing treatments Both Prime Medicine and Beam Therapeutics emerged from David Liu's twists on CRISPR. Now they're pursuing treatments for the same disease. By Jason Mast

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser